Tempest Therapeutics Balance Sheet Health
Financial Health criteria checks 5/6
Tempest Therapeutics has a total shareholder equity of $20.6M and total debt of $10.6M, which brings its debt-to-equity ratio to 51.4%. Its total assets and total liabilities are $44.4M and $23.7M respectively.
Key information
51.4%
Debt to equity ratio
US$10.60m
Debt
Interest coverage ratio | n/a |
Cash | US$32.33m |
Equity | US$20.63m |
Total liabilities | US$23.75m |
Total assets | US$44.38m |
Recent financial health updates
Financial Position Analysis
Short Term Liabilities: TPST's short term assets ($33.5M) exceed its short term liabilities ($10.7M).
Long Term Liabilities: TPST's short term assets ($33.5M) exceed its long term liabilities ($13.1M).
Debt to Equity History and Analysis
Debt Level: TPST has more cash than its total debt.
Reducing Debt: Insufficient data to determine if TPST's debt to equity ratio has reduced over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: TPST has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: TPST has sufficient cash runway for 1 years if free cash flow continues to reduce at historical rates of 10.9% each year.